Multivariable Analysis of Primary Care Physician Adherence to Guideline-recommended Pharmacotherapy of Stable Coronary Artery Disease

Por S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova
Publicado em 2021-03-01

Drug interchangeability: Clinical efficacy and safety

Por S. K. Zyryanov, S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev
Publicado em 2017-06-01

FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY)

Por S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
Publicado em 2018-05-01

SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION

Por S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev
Publicado em 2017-07-01

SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY)

Por S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
Publicado em 2017-05-01

The role of pharmacist in early phase clinical research

Por A. V. Vozzhaev, S. B. Fitilev, V. A. Yakushev, I. I. Shkrebneva
Publicado em 2018-05-01

Clinical significance of TNF-a assessment as inflammation marker in paroxysmal atrial fibrillation

Por E M Esedov, Z S Rustamova, S B Fitilev, I I Shkrebniova, A V Vozzhaev
Publicado em 2014-12-01

Medication adherence in patients with cardiovascular disease: current view of the problem

Por S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova, D. A. Kliuev, L. N. Stepanyan
Publicado em 2020-04-01

Comparison of medicamental secondary prevention of cardiovascular disease in ambulatory patients with myocardial infarction over a period of 2001-2006 (pharmacoepidemiological stud...

Por S B Fitilev, A V Vozzhaev, I I Shkrebneva, Y Y Titarova, E A Sicheva, R I Zhuravlev
Publicado em 2009-03-01

Safety, pharmacokinetics and pharmacodynamics of an original glycoprotein IIb/IIIa inhibitor in healthy volunteers: results of the clinical trial

Por S. B. Fitilev, Yu. F. Glukhov, S. V. Lukyanov, A. V. Vozzhaev, I. I. Shkrebniova, V. I. Kazey, I. B. Bondareva
Publicado em 2022-03-01

Lipid-lowering therapy in outpatients of different ages with coronary artery disease

Por S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova, N. N. Landyshev, Ya. G. Voronko, A. M. Lutsenko
Publicado em 2020-11-01

Effects of Pharmacy Care Program on medication adherence in outpatients with stable coronary artery disease: a randomized controlled study

Por S. B. Fitilev, A. V. Vozzhaev, D. A. Klyuev, I. I. Shkrebniova, N. N. Shindryaeva, L. N. Saakova, Yu. V. Shkirando
Publicado em 2022-01-01

Assessing the implementation of the recommendations on secondary cardiovascular prevention in patients after myocardial infarction (a pharmaco-epidemiologic study)

Por R. G. Oganov, V. K. Lepakhin, S. B. Fitilev, A. M. Levin, I. I. Shkrebneva, Yu. Yu. Titarova, A. V. Vozzhaev
Publicado em 2009-08-01

Adherence to Medical Treatment in Elderly Patients with Coronary Artery Disease in the Settings of Primary Outpatient Care

Por S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, N. N. Shindryaeva, D. A. Klyuev, L. N. Stepanyan, A. M. Lutsenko, A. T. Tsai, A. A. Danilova
Publicado em 2021-05-01

Results of a phase I open randomized comparative crossover clinical trial to assess the safety and pharmacokinetics of Glurazyme® (imiglucerase) in comparison with the reference pr...

Por S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, D. A. Kudlay, E. V. Gapchenko, O. A. Markova, A. Yu. Borоzinets, A. A. Kazarov, М. S. Pantyushenko
Publicado em 2019-12-01

Lipid-lowering therapy in patients with coronary artery disease in primary care practices: what has changed over 7 years?

Por S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, D. A. Klyuev, L. N. Stepanyan, A. A. Danilova, A. T. Tsai, N. N. Landyshev, Ya. G. Voronko
Publicado em 2020-09-01